Remove keyword ma
article thumbnail

Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P. Pearl O’Rourke, MD; David S. Wendler, PhD, MA; Miguel Vazquez, MD; P. Michael Ho, MD, PhD)

Rethinking Clinical Trials

Wendler, PhD, MA; Miguel Vazquez, MD; P.                                            Speakers Pearl O’Rourke, MD (retired) Harvard Medical School David S. Tags #pctGR, @Collaboratory1 The post Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P.

article thumbnail

Grand Rounds April 21, 2023: Personalised Cooler Dialysate for Patients Receiving Maintenance Haemodialysis (MyTEMP): A Pragmatic, Cluster-randomised Trial (Amit Garg, MD, MA, FRCPC, FACP, PhD; Stephanie N. Dixon, PhD MSc)

Rethinking Clinical Trials

Tags #pctGR, @Collaboratory1 The post Grand Rounds April 21, 2023: Personalised Cooler Dialysate for Patients Receiving Maintenance Haemodialysis (MyTEMP): A Pragmatic, Cluster-randomised Trial (Amit Garg, MD, MA, FRCPC, FACP, PhD; Stephanie N. degrees Celsius. Dixon, PhD MSc) appeared first on Rethinking Clinical Trials.

Trials 130
article thumbnail

A New, Automated Approach to Patient Identification for Clinical Trials

ACRP blog

Keyword searches, manual reviews, outdated reports, and other time-consuming and expensive methods are commonly used to find eligible candidates for enrollment. Mette Brøgger-Mikkelsen MA, et al. 2 These delays can be costly, resulting in potential estimated losses of $600,000 to $8 million per day. Perspect Clin Res 2020;11:51–3.